HMD Stock Overview
HeraMED Limited, together with its subsidiaries, develops, manufactures, and sells foetal heart beat monitors and other pregnancy monitoring solutions for home use in Australia, Europe, and Israel.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
HeraMED Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$0.018 |
| 52 Week High | AU$0.10 |
| 52 Week Low | AU$0.012 |
| Beta | -0.086 |
| 1 Month Change | -7.89% |
| 3 Month Change | -23.91% |
| 1 Year Change | -83.33% |
| 3 Year Change | -88.71% |
| 5 Year Change | -92.39% |
| Change since IPO | -90.28% |
Recent News & Updates
Recent updates
Shareholder Returns
| HMD | AU Medical Equipment | AU Market | |
|---|---|---|---|
| 7D | 0% | -2.4% | -3.0% |
| 1Y | -83.3% | 12.6% | 3.9% |
Return vs Industry: HMD underperformed the Australian Medical Equipment industry which returned 14.6% over the past year.
Return vs Market: HMD underperformed the Australian Market which returned 4.5% over the past year.
Price Volatility
| HMD volatility | |
|---|---|
| HMD Average Weekly Movement | 19.6% |
| Medical Equipment Industry Average Movement | 10.3% |
| Market Average Movement | 8.9% |
| 10% most volatile stocks in AU Market | 17.2% |
| 10% least volatile stocks in AU Market | 3.4% |
Stable Share Price: HMD's share price has been volatile over the past 3 months.
Volatility Over Time: HMD's weekly volatility (20%) has been stable over the past year, but is still higher than 75% of Australian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2011 | n/a | n/a | www.hera-med.com |
HeraMED Limited, together with its subsidiaries, develops, manufactures, and sells foetal heart beat monitors and other pregnancy monitoring solutions for home use in Australia, Europe, and Israel. It also provides HeraBEAT, a fetal heart rate monitor use by an expectant mother to monitor their fetus’ heartbeat; and HeraCARE, a cloud-based remote maternity care platform. The company has a collaboration agreement with Mayo Clinic for the development of its HeraCARE pregnancy management platform.
HeraMED Limited Fundamentals Summary
| HMD fundamental statistics | |
|---|---|
| Market cap | AU$6.18m |
| Earnings (TTM) | -AU$7.02m |
| Revenue (TTM) | AU$627.79k |
9.8x
P/S Ratio-0.9x
P/E RatioIs HMD overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| HMD income statement (TTM) | |
|---|---|
| Revenue | US$402.90k |
| Cost of Revenue | US$160.96k |
| Gross Profit | US$241.94k |
| Other Expenses | US$4.74m |
| Earnings | -US$4.50m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.013 |
| Gross Margin | 60.05% |
| Net Profit Margin | -1,117.60% |
| Debt/Equity Ratio | 38.1% |
How did HMD perform over the long term?
See historical performance and comparison